Molecular methods in the diagnosis of infections in the immunocompromised host

Current Opinion in Infectious Diseases

Volumn 13, Issue 4, 2000, Pages 355-359

  Hebart, Holger ^a   Loeffler, Juergen ^a   Kanz, Lothar ^a   Einsele, Hermann ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GALACTOMANNAN; GANCICLOVIR;

CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST; DISEASE PREDISPOSITION; DRUG MONITORING; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENETIC ANALYSIS; HUMAN; IMMUNE DEFICIENCY; INFECTION; LUNG LAVAGE; LYMPHOPROLIFERATIVE DISEASE; MYCOSIS; NONHUMAN; ORGAN TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STEM CELL TRANSPLANTATION;

EID: 0033845770     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200008000-00005     Document Type: Review

References (40)

1. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection
2. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients
3. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients
4. A randomized study comparing ganciclovir and foscarnet for preemptive therapy of CMV infection in allogeneic SCT recipients
5. Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: No need for surveillance
6. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
7. Multicenter comparison of the Digene Hybrid Capture CMV DNA assay (Version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia
8. Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation
9. Quality of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: Relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG)
10. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: Baseline CMV load dictates time to disease and survival
11. Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS
12. Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus positive patients
13. Evaluation of the AmpliSensor PCR and the SHARP signal detection system for the early prediction of symptomatic CMV infection in solid transplant recipients
14. Cytomegalovirus (CMV) retinitis activity is accurately reflected by the presence and level of CMV DNA in aqueous humor and vitreous
15. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence based amplification
16. The dynamics of human cytomegalovirus replication in vivo
17. Detection of Epstein Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders
18. Monitoring of Epstein Barr virus DNA load in peripheral blood by quantitative competitive PCR
19. Quantitative analysis of Epstein Barr virus load by using a real time PCR assay
20. Detection of Epstein Barr virus EBER sequence in post transplant lymphoma patients with DNA dendrimers
21. Activation and adoptive transfer of Epstein Barr virus specific cytotoxic T-cells in solid organ transplant patients with posttransplant lymphoproliferative disease
22. Focal brain lesions in acquired immunedeficiency syndrome: DNA diagnosis and further monitoring
23. Detection of Toxoplasma gondii, Epstein Barr virus, and JC virus DNAs in the cerebrospinal fluid in acquired immunodeficiency syndrome patients with focal central nervous system complications
24. Pulmonary toxoplasmosis in bone marrow transplant recipients: Report of two cases and review
25. High frequency of Toxoplasma reactivation documented by PCR in allogeneic stem cell transplant recipients not receiving trimethoprim-sulfamethoxazole
26. Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis
27. Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system
28. Amplification of the six major human herpesviruses from cerebrospinal fluid by a single PCR
29. Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: Frequency and clinical significance
30. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: Does it wave clinical significance?
31. Detection of human herpesvirus 6 by reverse transcription-PCR
32. Successful treatment of human herpesvirus 6 encephalitis after bone marrow transplantation
33. Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR
34. Detection of Pneumocystis carinii DNA in blood specimens from human immunodeficiency virus infected patients by nested PCR
35. Pneumocystis carinii genotypes and severity of pneumonia
36. Autopsy controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme linked immunosorbent assay for hematological patients at risk for invasive aspergillosis
37. Detection and identification of fungal pathogens in blood by using molecular probes
38. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system
39. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two step PCR
40. Rapid identification of fungi by using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system